BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 9687527)

  • 1. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11.
    Schust DJ; Tortorella D; Seebach J; Phan C; Ploegh HL
    J Exp Med; 1998 Aug; 188(3):497-503. PubMed ID: 9687527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.
    Barel MT; Ressing M; Pizzato N; van Leeuwen D; Le Bouteiller P; Lenfant F; Wiertz EJ
    J Immunol; 2003 Dec; 171(12):6757-65. PubMed ID: 14662880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation.
    Barel MT; Pizzato N; Le Bouteiller P; Wiertz EJ; Lenfant F
    Int Immunol; 2006 Jan; 18(1):173-82. PubMed ID: 16361314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules.
    Jun Y; Kim E; Jin M; Sung HC; Han H; Geraghty DE; Ahn K
    J Immunol; 2000 Jan; 164(2):805-11. PubMed ID: 10623826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules.
    Furman MH; Ploegh HL; Tortorella D
    J Biol Chem; 2002 Feb; 277(5):3258-67. PubMed ID: 11717308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains.
    Jones TR; Sun L
    J Virol; 1997 Apr; 71(4):2970-9. PubMed ID: 9060656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.
    Rehm A; Engelsberg A; Tortorella D; Körner IJ; Lehmann I; Ploegh HL; Höpken UE
    J Virol; 2002 May; 76(10):5043-50. PubMed ID: 11967320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains.
    Machold RP; Wiertz EJ; Jones TR; Ploegh HL
    J Exp Med; 1997 Jan; 185(2):363-6. PubMed ID: 9016885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
    Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
    J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying the ERAD ubiquitin E3 ligases for viral and cellular targeting of MHC class I.
    van den Boomen DJ; Lehner PJ
    Mol Immunol; 2015 Dec; 68(2 Pt A):106-11. PubMed ID: 26210183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol.
    van der Wal FJ; Kikkert M; Wiertz E
    Curr Top Microbiol Immunol; 2002; 269():37-55. PubMed ID: 12224515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection.
    Terauchi M; Koi H; Hayano C; Toyama-Sorimachi N; Karasuyama H; Yamanashi Y; Aso T; Shirakata M
    J Virol; 2003 Aug; 77(15):8187-95. PubMed ID: 12857887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I heavy chains for degradation.
    Barel MT; Hassink GC; van Voorden S; Wiertz EJ
    Mol Immunol; 2006 Mar; 43(8):1258-66. PubMed ID: 16098592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CD1d molecules are resistant to human cytomegalovirus US2- and US11-mediated degradation.
    Cho S; Jun Y
    Biochem Biophys Res Commun; 2011 Oct; 413(4):616-22. PubMed ID: 21925141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
    Johnson DC; Hegde NR
    Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAM1 participates in human cytomegalovirus US2- and US11-mediated dislocation of an endoplasmic reticulum membrane glycoprotein.
    Oresic K; Ng CL; Tortorella D
    J Biol Chem; 2009 Feb; 284(9):5905-14. PubMed ID: 19121997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation.
    Park B; Spooner E; Houser BL; Strominger JL; Ploegh HL
    J Exp Med; 2010 Aug; 207(9):2033-41. PubMed ID: 20713594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets.
    Llano M; Gumá M; Ortega M; Angulo A; López-Botet M
    Eur J Immunol; 2003 Oct; 33(10):2744-54. PubMed ID: 14515258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation.
    Falk CS; Mach M; Schendel DJ; Weiss EH; Hilgert I; Hahn G
    J Immunol; 2002 Sep; 169(6):3257-66. PubMed ID: 12218145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.
    Chevalier MS; Daniels GM; Johnson DC
    J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.